94444 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems; Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2 Radicals containing only hydrogen and carbon atoms
IRREVERSIBLE INACTIVATORS TARGETING ARAF/MEK COMPLEXES
#2LIGHT-RECEIVING DEVICE AND LIGHT-EMITTING AND LIGHT-RECEIVING APPARATUS
#3NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND ELECTRONIC APPARATUS
#4METHOD FOR MAKING A BENZIMIDAZOLE
#5METHOD FOR MAKING METHANE FROM CARBON DIOXIDE
#6CHEMICAL COMPOUNDS AND USES THEREOF
#7NOVEL INHIBITORS
#82-AMINO-5,5-DIMETHYLHEXANOIC ACID DERIVATIVES AS SORTILIN MODULATORS FOR USE IN THE TREATMENT OF DISEASE OF THE CENTRAL NERVOUS SYSTEM
#9AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY
#10COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES
#11BIMETALLIC NANOALLOY COMPOSITE
#12EMM-75 MOLECULAR SIEVE COMPOSITIONS, SYNTHESES, AND USES
#13NOVEL ANTI-FIBROTIC DRUGS
#14BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#15BENZIMIDAZOLE DERIVATIVES FOR TREATING RESPIRATORY DISEASE
#16ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF
#17METHODS OF COUPLING A CARBON CONTAINING MOIETY TO AN AMINE CONTAINING MOIETY
#18Benzimidazole derivatives
#19COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS
#20Inhibitors of VAP-1
#21INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF
#22BENZIMIDAZOLE-SUBSTITUTED FLUORANTHENE COMPOUND, AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME
#23Heterocyclic compound
#24Substituted Benzimidazole Derivative And Use Thereof
#25Light Emitting Device and Light Emitting Display Device Including the Same
#26NOVEL FORMS OF PRACINOSTAT DIHYDROCHLORIDE
#27Methods and Compositions for Targeting Tregs using CCR8 Inhibitors
#28ORGANOMETALLIC COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME
#29ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#30CYCLOALKANE-FUSED POLYCYCLIC AROMATIC COMPOUND
#31POLYCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND OR THE COMPOSITION
#32LIGHT-RECEIVING DEVICE AND LIGHT-EMITTING AND LIGHT-RECEIVING APPARATUS
#33COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#34ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE
#35ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#36ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#37HETEROCYLIC COMPOUND AND LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE HETEROCYCLIC COMPOUND
#38Aromatic sulfonamide derivatives
#39SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF
#40COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#41NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND ELECTRONIC APPARATUS
#42ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE USING SAME
#43NOVEL INHIBITORS
#44DHODH INHIBITORS AND THEIR USE AS ANTIVIRAL AGENTS
#45SMALL TUNABLE FLUOROPHORES FOR THE DETECTION AND IMAGING OF BIOMOLECULES
#46HYDRAZIDE COMPOUND AND KINASE INHIBITOR
#47COMPOUNDS FOR TREATING RESPIRATORY DISEASE
#48HDAC1,2 inhibitors
#49Bicyclic compounds and their use in the treatment of cancer
#50Inhibitors of VAP-1
#51Hydroxide-Catalyzed Formation Of Silicon-Oxygen Bonds By Dehydrogenative Coupling Of Hydrosilanes And Alcohols
#52Methods of coupling a carbon containing moiety to an amine containing moiety
#53Benzimidazoles and indoles as taro inhibitors
#542-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases
#55FTO Inhibitors
#56COMPOUNDS FOR TREATING DENGUE VIRUS INFECTIONS AND OTHER INFECTIONS
#57COMPOUNDS ACTING AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE
#58NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
#59Compounds with activity as inhibitors of the epithelial sodium channel (ENaC)
#60Heterocyclic compound
#61Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
#62Crystalline polymorphs of Pracinostat and Pracinostat salts
#632-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases
#64Organic Material for an Electronic Optoelectronic Device and Electronic Device Comprising the Organic Material
#65IMAGING HISTONE DEACETYLASES WITH A RADIOTRACER USING POSITRON EMISSION TOMOGRAPHY
#66BUMETANIDE DERIVATIVES FOR THE THERAPY OF HYPERHIDROSIS
#67Bicyclic compounds and their use in the treatment of cancer
#68Organic electroluminescent element and electronic device
#69Inhibitors
#70Fluorosulfonyl-containing compound, intermediate thereof, preparation method therefor and use thereof
#71Compounds and compositions for inhibition of FASN
#72Agricultural chemicals
#73POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE AND USES THEREOF
#742-arylbenzimidazoles as PPARGC1A activators for treating neurodegenerative diseases
#75Bicyclic compounds and their use in the treatment of cancer
#76Benzimidazoles and indoles as taro inhibitors
#77ANTHRACENE MATERIALS, ORGANIC LIGHT EMITTING DIODES, AND METHOD FOR MANUFACTURING ANTHRACENE MATERIALS
#78Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
#79Preparation of and formulation comprising a MEK inhibitor
#80FTO inhibitors
#811, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors
#82Chemoselective methylene hydroxylation in aromatic molecules
#83Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
#84Compounds and compositions for inhibition of FASN
#85Deuterated benzimidazole compound and medical use thereof
#86Benzimidazole compound and preparation method thereof
#87N-arylated analogues and uses thereof
#88Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
#89Organic light-emitting element
#90Benzimidazole derivatives: preparation and pharmaceutical applications
#91Glucosylceramide synthase inhibitors for the treatment of diseases
#92Benzimidazole derivatives as PI3 kinase inhibitors
#93Hydroxide-catalyzed formation of silicon-oxygen bonds by dehydrogenative coupling of hydrosilanes and alcohols
#94Compounds and compositions for inhibition of FASN
#95Compounds and compositions for inhibition of FASN
#96Imaging histone deacetylases with a radiotracer using positron emission tomography
#97Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
#98Methods of forming carbene-functionalized composite materials
#99Polymorphic forms of 3-[(2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acrylamide and uses thereof
#100NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#101One-pot homogeneous process for the large scale manufacture of 2-substituted benzimidazoles
#102Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute
#103Substituted carboxamides as inhibitors of WDR5 protein-protein binding
#104Aromatic sulfonamide derivatives
#105Tetraphenylene anthracene compounds
#106Compounds and compositions for inhibition of FASN
#107Microbiocidal phenylamidine derivatives
#108Near-infrared-absorbing dye, optical filter, and imaging device
#109AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY
#110Preparation of and formulation comprising a MEK inhibitor
#111Benzimidazole derivatives as PI3 kinase inhibitors
#112Farnesoid X receptor agonists and uses thereof
#113Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof
#114Selective inhibitors of carbonic anhydrase
#115Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#116Organic electroluminescence device
#1172-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitors
#118SYNTHESIS OF A COMPOUND THAT MODULATES THE ACTIVITY OF BROMODOMAIN-CONTAINING PROTEINS
#119Benzimidazole compound and medical use thereof
#120Organic electroluminescent element and electronic device
#121Imidazolyl tricyclic enones as antioxidant inflammation modulators
#122FTO inhibitors
#123Phosphatidylinositol 3-kinase inhibitors
#124Inhibitors of human immunodeficiency virus replication
#125Compounds and compositions for inhibition of FASN
#126Neprilysin inhibitors
#127Determination of aqueous nitrate concentration
#128Organic electroluminescent device
#129Benzimidazole derivatives: preparation and pharmaceutical applications
#130Oxygen-containing fused ring amine compound, sulfur-containing fused ring amine compound and organic electroluminescence device
#131Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors
#132Broad-spectrum non-covalent coronavirus protease inhibitors
#133Aromatic amine derivative and organic electroluminescent element using same
#134HETEROCYCLIC COMPOUNDS AS DCTPP1 MODULATORS
#135Preparation method for Bemaciclb
#136Electron transport materials with selected dipole moments
#137Organic EL device and display unit
#138Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
#139Selective HDAC3 inhibitors
#140Electronic device including a fluoranthene derivative
#141Five-membered heterocycles useful as serine protease inhibitors
#142Modulators of the relaxin receptor 1
#143Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
#144Antiviral drugs for treatment of arenavirus infection
#145Benzimidazole compounds and medical uses thereof
#146Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto
#147Surface treating composition for copper and copper alloy and utilization thereof
#148Organic electroluminescent element and electronic device
#149Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#1505-aminopyrazole-4-carboxamide inhibitors of CDPK1 from T. gondii and C. parvum
#151Hydroxide-catalyzed formation of silicon-oxygen bonds by dehydrogenative coupling of hydrosilanes and alcohols
#152Neprilysin inhibitors
#153Heteroaromatic derivatives and their use as pharmaceuticals
#154Benzimidazole derivatives as selective blockers of persistent sodium current
#155Compound and epoxy resin composition containing same
#156Benzimidazole and imadazopyridine carboximidamide compounds
#157Benzimidazoles and their use in the treatment of tuberculosis
#158Compositions for the treatment of hypertension and/or fibrosis
#159Benzimidazole derivatives: preparation and pharmaceutical applications
#160SUBSTITUTED PHENYLALANINE DERIVATIVES
#161Imaging histone deacetylases with a radiotracer using positron emission tomography
#162Electronic device including a fluoranthene derivative
#1633-aminocyclopentane carboxamide derivatives
#164Onium salt compound, resist composition, and pattern forming process
#165Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#166Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
#167Glucosylceramide synthase inhibitors for the treatment of diseases
#168Store overload-induced calcium release inhibitors and methods for producing and using the same
#169ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#170Organic electroluminescent element and electronic device
#171Aromatic amine compound, organic electroluminescent element and electronic device
#172Preparation of and formulation comprising a MEK inhibitor
#173Preparation of and formulation comprising a MEK inhibitor
#174Method for preparation of benzimidazole derivatives
#175CYP17 inhibitors/antiandrogens
#1765-aminopyrazole-4-carboxamide inhibitors of CDPK1 from and
#177Polycyclic compound and organic light emitting device including the same
#178Heterocyclic derivative and pharmaceutical drug
#179Histone deacetylase inhibitors and compositions and methods of use thereof
#180Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
#181Benzimidazole derivatives and uses thereof
#182Hydrogen sulfate salt
#183Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof
#184NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
#185Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
#186Amine derivative or salt thereof
#187Selective HDAC3 inhibitors
#188Use of benzo five-membered nitrogen heterocyclic piperazine or piperidine derivatives
#189Tricyclic compound
#190Five-membered heterocycles useful as serine protease inhibitors
#191N-acylhydrazone derivatives for selective T cell inhibitor and anti-lymphoid malignancy drug
#192Benzimidazole derivatives as PI3 kinase inhibitors
#193MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES
#194Neprilysin inhibitors
#195Ring-fused compound
#196Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
#197SELECTIVE INHIBITORS OF HISTONE DEACETYLASE ISOFORM 6 AND METHODS THEREOF
#198Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
#199Sulfonamide derivative having PGD2 receptor antagonistic activity
#200Benzimidazole derivatives: preparation and pharmaceutical applications
#201N-biphenylmethylbenzimidazole modulators of PPARG
#202Organic electronic material and organic electroluminescent device
#203METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, AND SCREENING ASSAYS FOR IDENTIFYING COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION
#204Inhibitors of hepatitis B virus covalently closed circular DNA formation and their method of use
#205N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides
#206Benzimidazole derivatives as PI3 kinase inhibitors
#207Neprilysin inhibitors
#2085-oxo-ETE receptor antagonist compounds
#209Kinase inhibitors
#210Substituted benzimidazoles
#211Organic electroluminescent element
#212NOVEL HYDROGEN SULFATE SALT
#213Heterocyclic derivative and pharmaceutical drug
#214Composition for treating hepatitis C virus, regulating phosphorylation of replicase
#215Five-membered heterocycles useful as serine protease inhibitors
#216Use of organic compound for the treatment of Noonan Syndrome
#217Apoptosis promoters
#218Oxygen-containing fused ring amine compound, sulfur-containing fused ring amine compound and organic electroluminescence device
#219Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto
#220Cyano-benzimidazole salts for electrochemical cells and method for synthesis thereof
#221Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
#222Benzimidazole derivatives as PI3 kinase inhibitors
#223Dual-acting benzoimidazole antihypertensive agents
#224Surface treating composition for copper and copper alloy and utilization thereof
#225Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators
#226Antimicrobial and radioprotective compounds
#227Inhibitors of the shiga toxins trafficking through the retrograde pathway
#228Methods of Treating Neuropathic Pain with Benzimidazole Derivative Agonists of PPARgamma
#229Benzimidazole derivatives as PI3 kinase inhibitors
#230Ring-fused compound
#231Benzimidazole derivatives: preparation and pharmaceutical applications
#232Organic electroluminescent element
#233DIPHENYL-AMINE DERIVATIVES: USES, PROCESS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS
#234Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
#235Neprilysin inhibitors
#236Benzimidazole derivatives as PI3 kinase inhibitors
#237Benzimidazole Derivatives As PI3 Kinase Inhibitors
#238Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
#239METHOD OF MAKING BENZAZOLES
#240Benzimidazole derivatives as selective blockers of persistent sodium current
#241Heterocyclic compound, and composition for treating inflammatory diseases using same
#242Biaryl oxyacetic acid compounds
#243Arylsulfonamide based matrix metalloprotease inhibitors
#244Compound for organic electroluminescent device and organic electroluminescent devices using the same
#245Antimicrobial compositions and methods of use thereof
#246STYRENE-BASED COPOLYMERS, IN PARTICULAR FOR USE IN OPTOELECTRONIC COMPONENTS
#247Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#248Chemical Compounds
#249Methods and compositions of treating a flaviviridae family viral infection
#250Arylsulfonamide based matrix metalloprotease inhibitors
#251Hydrogen sulfate salt
#252N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides
#253Dual-acting benzoimidazole antihypertensive agents
#254Antimicrobial and radioprotective compounds
#255Neprilysin inhibitors
#256Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same
#2575-oxo-ETE receptor antagonist compounds
#258Crosslinked pi-conjugated heteroacene compound for organic electroluminescence device and organic electroluminescence device using the same
#259AZOLE DERIVATIVES AND FUSED BICYCLIC AZOLE DERIVATIVES AS THERAPEUTIC AGENTS
#260Benzimidazole derivatives as P13 kinase inhibitors
#261Five-membered heterocycles useful as serine protease inhibitors
#262Crosslinked pi-conjugated heteroacene compound for organic electroluminescence device and organic electroluminescence device using the same
#263Antiviral drugs for treatment of arenavirus infection
#264Nitrogen-containing organic compound, chemically amplified positive resist composition, and patterning process
#265Aromatic amine derivative and organic electroluminescent element comprising the same
#266Compound
#267Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
#268Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
#269Aromatic amine derivative and organic electroluminescence device using the same
#270Chemical compounds
#271GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES
#272Aromatic amine derivative and organic electroluminescent element using same
#273TAAR1 LIGANDS
#274LIGHT-EMITTING ELEMENT MATERIAL AND LIGHT-EMITTING ELEMENT
#2757-Hydroxy-benzoimidazole-4-yl-methanone Derivatives and PBK Inhibitors Containing the Same
#276Apoptosis promoters
#277Substituted naphto[2,3-f]quinoxaline-7,12-diones and pharmaceutical utility thereof
#278Plating bath and method
#279Tricyclic compound
#280Inhibitors of the Shiga toxins trafficking through the retrograde pathway
#281BENZIMIDAZOLE MODULATORS OF VR1
#282BENZIMIDAZOLE MODULATORS OF VR1
#283NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP
#284Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors
#285Apoptosis promoters
#286Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
#287Anthracene derivative and an organic electronic device using the same
#288BENZIMIDAZOLE ACETIC ACIDS EXHIBITING CRTH2 RECEPTOR ANTAGONISM AND USES THEREOF
#289Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound
#290IRE-1α inhibitors
#291Methods of treating a family viral infection and compositions for treating a family viral infection
#292PROLYL HYDROXYLASE INHIBITORS
#293Materials for organic electroluminescence device
#294Fluorine derivatives for organic electroluminescence devices
#295Benzimidazole Compounds
#296Methods of treating neuropathic pain with benzimidazole derivative agonists of PPARgamma
#297Arylsulfonamide-based matrix metalloprotease inhibitors
#298Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same
#299Compound
#300HETEROCYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS